p.131 抽出テキスト

artery calcium in individuals with absent coronary calcification: the MESA. Circ Cardiovasc Imaging 2021;14:e011701. https://doi.org/10.1161/circimaging.120.011701 208. Gepner AD, Young R, Delaney JA, Budoff MJ, Polak JF, Blaha MJ, et al. Comparison of carotid plaque score and coronary artery calcium score for predicting cardiovascular disease events: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2017;6: e005179. https://doi.org/10.1161/jaha.116.005179 209. Laclaustra M, Casasnovas JA, Fernández-Ortiz A, Fuster V, León-Latre M, Jiménez-Borreguero LJ, et al. Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study. J Am Coll Cardiol 2016;67:1263–74. https://doi.org/10.1016/j.jacc.2015.12.056 210. Jacobowitz GR, Rockman CB, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. A model for predicting occult carotid artery stenosis: screening is justified in a selected population. J Vasc Surg 2003;38:705–9. https://doi.org/10.1016/s0741- 5214(03)00730-4 211. Rockman CB, Jacobowitz GR, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. Focused screening for occult carotid artery disease: patients with known heart disease are at high risk. J Vasc Surg 2004;39:44–50. https://doi.org/10.1016/j.jvs.2003.07.008 212. Yuo TH, Sidaoui J, Marone LK, Makaroun MS, Chaer RA. Revascularization of asymptomatic carotid stenosis is not appropriate in patients on dialysis. J Vasc Surg 2015;61: 670–4. https://doi.org/10.1016/j.jvs.2014.10.002 213. Ramos MJ, González-Fajardo JA, Vaquero-Puerta C, Vallina-Victorero M, Vicente-Santiago M, Vaquero-Lorenzo F, et al. Asymptomatic carotid stenosis in patients with intermittent claudication: epidemiological study. J Cardiovasc Surg (Torino) 2011;52:761–8 . 214. Aboyans V, Lacroix P, Guilloux J, Rollé F, Le Guyader A, Cautrès M, et al. A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2005;4:90–5. https://doi.org/10.1510/icvts. 2004.092262 215. Cornily JC, Le Saux D, Vinsonneau U, Bezon E, Le Ven F, Le Gal G, et al. Assessment of carotid artery stenosis before coronary artery bypass surgery. Is it always necessary? Arch Cardiovasc Dis 2011;104:77–83. https://doi.org/10.1016/j.acvd.2010.11.008 216. Johansson EP, Wester P. Carotid bruits as predictor for carotid stenoses detected by ultrasonography: an observational study. BMC Neurol 2008;8:23. https://doi.org/10. 1186/1471-2377-8-23 217. Carmody BJ, Arora S, Avena R, Curry KM, Simpkins J, Cosby K, et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg 1999;30:1045–51. https://doi.org/10.1016/ s0741-5214(99)70042-x 218. Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019;7:e1020–30. https://doi.org/10. 1016/s2214-109x(19)30255-4 219. Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: past, present, and future. Am J Med 2019;132:1133–41. https://doi.org/10.1016/j. amjmed.2019.04.043 220. Søgaard R, Lindholt JS. Cost-effectiveness of population-based vascular disease screening and intervention in men from the Viborg Vascular (VIVA) trial. Br J Surg 2018;105: 1283–93. https://doi.org/10.1002/bjs.10872 221. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005;330:750. https://doi.org/ 10.1136/bmj.38369.620162.82 222. Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329:1259. https://doi.org/10.1136/bmj. 38272.478438.55 223. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. The multicentre aneurysm screening study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360: 1531–9. https://doi.org/10.1016/s0140-6736(02)11522-4 224. Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995;82:1066–70. https://doi.org/10.1002/bjs.1800820821 225. Duncan A, Maslen C, Gibson C, Hartshorne T, Farooqi A, Saratzis A, et al. Ultrasound screening for abdominal aortic aneurysm in high-risk women. Br J Surg 2021;108: 1192–8. https://doi.org/10.1093/bjs/znab220 226. Lindholt JS, Sogaard R, Rasmussen LM, Mejldal A, Lambrechtsen J, Steffensen FH, et al. Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial. N Engl J Med 2022;387:1385–94. https://doi.org/10.1056/NEJMoa2208681 227. Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM. Population-based study of incidence of acute abdominal aortic aneurysms with projected impact of screening strategy. J Am Heart Assoc 2015;4:e001926. https://doi. org/10.1161/JAHA.115.001926 228. Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM. Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population. Br J Surg 2015;102:907–15. https://doi.org/10.1002/bjs.9838 229. Sprynger M, Willems M, Van Damme H, Drieghe B, Wautrecht JC, Moonen M. Screening program of abdominal aortic aneurysm. Angiology 2019;70:407–13. https:// doi.org/10.1177/0003319718824940 230. Larsson E, Granath F, Swedenborg J, Hultgren R. A population-based case-control study of the familial risk of abdominal aortic aneurysm. J Vasc Surg 2009;49:47–50; discussion 51. https://doi.org/10.1016/j.jvs.2008.08.012 231. Linné A, Forsberg J, Lindström D, Ideskog E, Hultgren R. Age at detection of abdominal aortic aneurysms in siblings of patients with abdominal aortic aneurysms. J Vasc Surg 2016;63:883–7. https://doi.org/10.1016/j.jvs.2015.10.057 232. Aboyans V, Bataille V, Bliscaux P, Ederhy S, Filliol D, Honton B, et al. Effectiveness of screening for abdominal aortic aneurysm during echocardiography. Am J Cardiol 2014;114:1100–4. https://doi.org/10.1016/j.amjcard.2014.07.024 233. Hicks CW, Al-Qunaibet A, Ding N, Kwak L, Folsom AR, Tanaka H, et al. Symptomatic and asymptomatic peripheral artery disease and the risk of abdominal aortic aneurysm: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2021;333:32–8. https://doi.org/10.1016/j.atherosclerosis.2021.08.016 234. Benson RA, Poole R, Murray S, Moxey P, Loftus IM. Screening results from a large United Kingdom abdominal aortic aneurysm screening center in the context of optimizing United Kingdom National Abdominal Aortic Aneurysm Screening Programme protocols. J Vasc Surg 2016;63:301–4. https://doi.org/10.1016/j.jvs.2015.08.091 235. Sciria CT, Osorio B, Wang J, Lu DY, Amin N, Vohra A, et al. Sex-based disparities in outcomes with abdominal aortic aneurysms. Am J Cardiol 2021;155:135–48. https:// doi.org/10.1016/j.amjcard.2021.06.023 236. Carter JL, Morris DR, Sherliker P, Clack R, Lam KBH, Halliday A, et al. Sex-specific associations of vascular risk factors with abdominal aortic aneurysm: findings from 1.5 million women and 0.8 million men in the United States and United Kingdom. J Am Heart Assoc 2020;9:e014748. https://doi.org/10.1161/JAHA.119.014748 237. Wanhainen A, Lundkvist J, Bergqvist D, Bjorck M. Cost-effectiveness of screening women for abdominal aortic aneurysm. J Vasc Surg 2006;43:908–14; discussion 914. https://doi.org/10.1016/j.jvs.2005.12.064 238. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010;92:1189–96. https://doi.org/10.3945/ajcn.2010.29673 239. Mente A, Dehghan M, Rangarajan S, O’Donnell M, Hu W, Dagenais G, et al. Diet, cardiovascular disease, and mortality in 80 countries. Eur Heart J 2023;44:2560–79. https://doi.org/10.1093/eurheartj/ehad269 240. Wan D, Dehghan M, de Souza RJ, Ramasundarahettige C, Eikelboom JW, Bosch J, et al. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort. Eur J Prev Cardiol 2023;30:709–18. https://doi. org/10.1093/eurjpc/zwad062 241. Adegbola A, Behrendt CA, Zyriax BC, Windler E, Kreutzburg T. The impact of nutrition on the development and progression of peripheral artery disease: a systematic review. Clin Nutr 2022;41:49–70. https://doi.org/10.1016/j.clnu.2021.11.005 242. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/ EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111–88. https://doi.org/10.1093/eurheartj/ehz455 243. Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lee B-C, et al. Benefit of targeting a LDL (low-density lipoprotein) cholesterol <70 mg/dL during 5 years after ischemic stroke. Stroke 2020;51:1231–9. https://doi.org/10.1161/strokeaha.119.028718 244. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007;4:CD000123. https:// doi.org/10.1002/14651858.CD000123.pub2 245. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007;45:645–54; discussion 653–644. https://doi.org/10.1016/j.jvs. 2006.12.054 246. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78. https://doi.org/10.1016/S0140-6736(05)67394-1 247. Bonaca MP, Gutierrez JA, Cannon C, Giugliano R, Blazing M, Park J-G, et al. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. Lancet Diabetes Endocrinol 2018;6:934–43. https://doi.org/10. 1016/s2213-8587(18)30290-0 248. Yu E, Malik VS, Hu FB. Cardiovascular disease prevention by diet modification: JACC health promotion series. J Am Coll Cardiol 2018;72:914–26. https://doi.org/10.1016/j. jacc.2018.02.085 249. López-Laguna N, Martínez-González MA, Toledo E, Babio N, Sorlí JV, Ros E, et al. Risk of peripheral artery disease according to a healthy lifestyle score: the PREDIMED study. Atherosclerosis 2018;275:133–40. https://doi.org/10.1016/j.atherosclerosis. 2018.05.049 250. Kaluza J, Stackelberg O, Harris HR, Akesson A, Björck M, Wolk A. Mediterranean diet is associated with reduced risk of abdominal aortic aneurysm in smokers: results of two prospective cohort studies. Eur J Vasc Endovasc Surg 2021;62:284–93. https:// doi.org/10.1016/j.ejvs.2021.04.017 Downloaded from academic.oup.com/eurheartj/article/45/36/3538/7738955 by guest on 07 October 2026